Navigation Links
Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
Date:9/9/2010

BASKING RIDGE, N.J., Sept. 9 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Stifel Nicolaus Healthcare Conference at the Four Seasons Hotel located at 200 Boylston Street in Boston, Massachusetts.  Dr. Mazzo's presentation will be given at 2:40 pm EDT in the Winthrop Room and will include an overview of the Company's pipeline with emphasis on the lead development program, the innovative anticoagulant system, REG1.

ABOUT REGADO BIOSCIENCES

Regado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent.  This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrombotics, uniquely concomitantly minimizing the risk of ischemia and bleeding, and, by allowing patient specific tuning of the desired therapeutic effect, providing a safe and unique approach to personalized medicine.

ABOUT REG1, REG2 and REG3

Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents both administered by IV bolus, the first being a potent highly selective Factor IXa inhibitor (pegnivacogin, a.k.a. RB006) and the second being its complementary active control agent (anivam
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
6. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
7. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
8. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
9. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
10. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
11. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 Every ... more research to fight heart disease.  Nevertheless, year after ... on ElectroCardioGrams (EKG) as the first test to determine ... they have chest pain or not, even though that ... occurs despite the fact that doctors know, (while most ...
(Date:2/26/2015)... Feb. 26, 2015 Research and Markets ... "Radiation Therapy Equipment - Global Strategic Business Report" ... report analyzes the worldwide markets for Radiation Therapy Equipment ... Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. The ... Canada , Japan , ...
(Date:2/26/2015)... 2015  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of Hepatitis B virus (HBV) and other viral ... million financing. Funds from this financing will accelerate ... spectrum antiviral agent derived from Spring Bank,s ... platform, into Phase II clinical trials for the ...
Breaking Medicine Technology:National Heart Health Month In February 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... standard has replaced the Statement on Auditing Standards No. ... Standards for Attestation Engagements No. 16 (SSAE 16), became ... to enforce a stronger set of controls and more ... Rising Medical Solutions has taken the first ...
... ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced ... Global Healthcare Conference in London. Dr. Ramin Mojdeh, Executive ... to present at 5:00 p.m. British Summer Time (12:00 ... The conference presentation will be broadcast over the ...
Cached Medicine Technology:Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 2Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 3Unilife to Present at the Jefferies 2011 Global Healthcare Conference in London 2
(Date:2/27/2015)... Undocumented farmworkers are half as ... Medicaid, the federal health insurance program available to ... study from UC Davis Health System. The research ... use of Medicaid, which provides coverage for prenatal, ... was having children. , “Undocumented agricultural workers ...
(Date:2/27/2015)... Royal River Natural Foods, a locally-owned independent natural health ... adults who got the most magnesium were less than half ... who got the least magnesium, with the largest benefit in ... part of the March 2015 issue of “ Natural Insights ... free each month for the Freeport community to learn more ...
(Date:2/27/2015)... Los Angeles, CA (PRWEB) February 27, 2015 ... article titled “The Real Liquid Botox ,” that details ... type A that is working its way through FDA trials. ... Botox cream is very attractive. Of course, if ... only by prescription at a physician’s office. (see: goo.gl/PQvQwk) , ...
(Date:2/27/2015)... 2015 Winter is here, and with it ... exposure to snow and ice can be harmful on a ... paws. The Puppy Store is ready to help pet owners ... safe in the winter time. , Ice melts can lead ... other symptoms. Ingestion of ice melt products may cause depression, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Victorian Hotel ... deals for couples who wanted to spend the auspicious ... opportunity to get a jump on Valentine’s Day with ... stay in one of their luxurious rooms. , ... 13, inviting guests for a mouthwatering 3 course meal ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Is Topical Botox the Next Big Thing? 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2
... Mice given BH4 had lower production of toxic free radicals ... News) -- Tests on mice suggest that the drug BH4 ... hearts, says a Johns Hopkins University study. , Currently, BH4 ... a metabolic disorder in which a toxic buildup of a ...
... ImmuKnow(R) to assess, immune cell function, will be presented at the annual ... ... Md., May 30 On Saturday, May 31 through,Tuesday, June 3, at ... presentations will either report,specifically on studies of the use of the ImmuKnow ...
... Hydus, Inc. ( http://www.hydus.com ), an,Enterprise ... to,Sponsor Informatica World 2008,( http://www.informatica.com/events/customer_conference/default.htm ) from,June ... Las Vegas, in Las Vegas, NV.,Informatica World ... conferences of,2008 where IT Professionals and service ...
... of North Carolina at Chapel Hill School of Public ... Johnson Foundation (RWJF) to explore how interactive digital games ... UNC joins 11 other research teams supported in this ... RWJF national program established to strengthen the evidence base ...
... men,s sexual appetite. But stimulating new research in the ... the eye. A recent study shows that men who ... when they were making decisions about money, soda, and ... and Luk Warlop (KULeuven, Belgium) found that the desire ...
... to Eat Right, Move More ... and Milk Their Diets, KANSAS CITY, Mo., May ... different fad diets -- which seem to go in and out,of fashion like ... Americans -- including 23 percent of Kansas City,residents -- remain overweight or obese., ...
Cached Medicine News:Health News:Genetic Disorder Drug Helps Reverse Heart Muscle Enlargement 2Health News:Multiple Independent Studies Report on Use of Cylex's Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients 2Health News:Multiple Independent Studies Report on Use of Cylex's Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients 3Health News:Multiple Independent Studies Report on Use of Cylex's Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients 4Health News:Multiple Independent Studies Report on Use of Cylex's Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients 5Health News:Multiple Independent Studies Report on Use of Cylex's Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients 6Health News:Hydus, Inc. Sponsors Informatica World 2008 2Health News:UNC health researchers explore how to take interactive video games to the next level 2Health News:UNC health researchers explore how to take interactive video games to the next level 3Health News:Message to Kansas City, MO Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Kansas City, MO Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3
... durable, the Medelec Synergy N-EP provides ... of a smaller instrument is driven ... take your testing equipment on the ... solution. The 2, 5, or 10-channel ...
Neuropack MEB-2200 evoked potential/EMG measuring system is user friendly Windows NT, Pentium III PC-based EP/EMG measuring system....
Sierra Wave Quickreport eliminates most dictation. Study driven functions make testing faster and easier. Complete 2/4 channel EMG/NCV/EP....
...
Medicine Products: